Clin2
NCT06734832Possibly a fitRecruiting

Vaccine trial for hand, foot, and mouth disease

Hand, Foot, and Mouth Disease(HFMD)

Part of Infections clinical trials.

This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
8,000 people
Ages
6 months to 5.9 years
Study type
Interventional

Who can take part

  • Your child is between 6 months and 5 years old (71 months).
  • Your child has not had a hand, foot, and mouth disease vaccine before (or has had two doses of EV71 vaccine at least 6 months ago).
  • Your child is generally healthy, with no serious ongoing illnesses like heart disease, immune problems, or neurological disorders.
  • Your child has not taken immune-suppressing medicines or received blood products in the last 6 months.
  • Your child has not had any other vaccines in the last 2 weeks and is not currently sick with a fever or infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07611513Not yet recruiting· Phase 3
Tetravalent enterovirus vaccine safety and effectiveness study

This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.

Hefei, Anhui
NCT07326878Not yet recruiting· Phase 1
Testing a two-in-one vaccine for hand, foot, and mouth disease

This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.

Chongqing, Chongqing Municipality
NCT07793175Not yet recruiting
EV71 vaccine study for Vietnamese children

This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.

Ho Chi Minh City
NCT07144202Enrolling by invitation
Long-term protection study after EV71 vaccination

This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.

Guilin, Guangxi
NCT06605755Recruiting
Testing a pentavalent vaccine in 2-month-old babies

This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.

Nanjing, Jiangsu
NCT06146088Recruiting· Phase 4
EV71 Vaccine Consistency Study for Children

This study tests three batches of an EV71 vaccine (which prevents hand, foot, and mouth disease) to see if they work the same. Your child would receive two doses, several weeks apart, and have blood tests to check their immune response.

Baoji, Shaan XI

Hear when a new Hand, Foot, and Mouth Disease(HFMD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.